To evaluate the utility of whole-body FDG-PET/CT in characterizing the extent of spinal tuberculosis (STB) and its implications for clinical practice.
Key Findings:
The proportion of disseminated disease increased from 40% to 60% with PET/CT findings, raising questions about the accuracy of traditional diagnostic methods.
FDG uptake may reflect inflammation or prior infections, leading to potential overestimation of disease dissemination.
The clinical implications of additional PET/CT lesions remain uncertain regarding treatment and management, necessitating further investigation.
Interpretation:
The study suggests that while PET/CT can identify a higher burden of disease, its clinical utility and implications for management are not clearly established, highlighting the need for further research.
Limitations:
Definition of disseminated STB may overestimate true dissemination due to nonspecific FDG uptake.
Uncertainty about the impact of additional PET/CT findings on clinical management.
Need for correlation of PET parameters with established disease severity markers and longitudinal studies.
Conclusion:
Further validation and contextualization of PET/CT findings are needed to establish their clinical relevance and utility in managing spinal tuberculosis, particularly in identifying specific areas for future research.
